Publication: Spanish consensus on infantile haemangioma
No Thumbnail Available
Identifiers
Date
2016-11-01
Authors
Torres, Eulalia Baselga
Wittel, Jose Bernabeu
van Esso Arbolave, Diego L.
Febrer Bosch, Maria Isabel
Sanz, Angel Carrasco
Laguna, Raul de Lucas
Losada, Jesus del Pozo
Martin, Angela Hernandez
Montanes, Lorenzo Jimenez
Lopez Gutierrez, Juan Carlos
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Ediciones doyma s a
Abstract
Introduction: Infantile haemangiomas are benign tumours produced by the proliferation of endothelial cells of blood vessels, with a high incidence in children under the age of one year (4-10%). It is estimated that 12% of them require treatment. This treatment must be administered according to clinical practice guidelines, expert experience, patient characteristics and parent preferences.Methods: The consensus process was performed by using scientific evidence on the diagnosis and treatment of infantile haemangiomas, culled from a systematic review of the literature, together with specialist expert opinions. The recommendations issued were validated by the specialists, who also provided their level of agreement.Results: This document contains recommendations on the classification, associations, complications, diagnosis, treatment, and follow-up of patients with infantile haemangioma. It also includes action algorithms, and addresses multidisciplinary management and referral criteria between the different specialities involved in the clinical management of this type of patient.Conclusions: The recommendations and the diagnostic and therapeutic algorithms of infantile haemangiomas contained in this document are a useful tool for the proper management of these patients. (C) 2015 Asociacion Espanola de Pediatria. Published by Elsevier Espana, S.L.U. All rights reserved.
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
Haemangioma/diagnosis, Haemangioma/drug therapy, Haemangioma/complications, Haemangioma/classification, Propranolol, Infant, Algorithms, Clinical characteristics, Phace syndrome, Risk-factors, Propranolol, Management, Complications, Infancy, Timolol, Cohort